aTyr Pharma | LIFE - Current Assets


aTyr Pharma reported $93.01M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Ardelyx USD 367.98M 16.42M Sep/2025
aTyr Pharma USD 93.01M 5.52M Sep/2025
Biogen USD 8.97B 37.5M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
CSL USD 11.85B 542M Jun/2025
Curis USD 14.42M 10.39M Jun/2025
Galapagos EUR 3.16B 93.29M Sep/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Grifols EUR 6.28B 92.48M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
United Therapeutics USD 3.49B 332.9M Sep/2025
Xoma USD 110.71M 5.78M Sep/2025